Introduction The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE) reporting. A grading (severity) scale is provided for …

An in-situ cancer fulfills all pathological criteria for malignancy except that it has not invaded the supporting structure of the organ or tissue in which it arose.

Primary Site See the Breast Solid Tumor Rules Equivalent Terms and Definitions for a list of terms used to describe location and their corresponding ICD-O-3 topography codes.

Note: A sleeve lobectomy/bilobectomy includes resection of the entire lobe(s) in addition to part of the bronchus. A sleeve lobectomy is distinct from a typical lobectomy or bilobectomy, in which the …

The main goal of Cancer PathCHART is to improve cancer surveillance data quality by updating standards for tumor site, histology, and behavior code combinations and associated terminology.

This guideline describes a standard approach to solid tumour measurement and definitions for objective assessment of change in tumour size for use in adult and paediatric cancer clinical trials.

C180–C189 Code removal/surgical ablation of single or multiple liver metastases under the data item Surgical Procedure of Other Site (NAACCR #1294).

B250 Local excision of tumor, NOS; example: Enucleation Laser tumor destruction, thermal therapy, or ablation

The excisional breast biopsy for ADH diagnosed the cancer, not the core biopsy. An excisional breast biopsy removes the entire tumor and/or leaves only microscopic margins.

Do not report bladder cancer based on UroVysion test results alone. Report the case if there is a physician statement of malignancy and/or the patient was treated for cancer.